Atovaquone proguanil how supplied: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Atovaquone proguanil}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MALARONE (ATOVAQUONE AND PROGUANIL...") |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==How Supplied/Storage And Handling== | |||
MALARONE Tablets, containing 250 mg atovaquone and 100 mg proguanil hydrochloride. | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc22e8d8-3bfb-4f70-a599-dd81262a4887 | publisher = | date = | accessdate = }}</ref> | •Bottle of 100 tablets with child-resistant closure (NDC 0173-0675-01). | ||
•Unit Dose Pack of 24 (NDC 0173-0675-02). | |||
MALARONE Pediatric Tablets, containing 62.5 mg atovaquone and 25 mg proguanil hydrochloride. | |||
•Bottle of 100 tablets with child-resistant closure (NDC 0173-0676-01). | |||
==Storage Conditions== | |||
Store at 25°C (77°F). Temperature excursions are permitted to 15° to 30°C (59° to 86°F) (see USP Controlled Room Temperature).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc22e8d8-3bfb-4f70-a599-dd81262a4887 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== |
Latest revision as of 05:28, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
How Supplied/Storage And Handling
MALARONE Tablets, containing 250 mg atovaquone and 100 mg proguanil hydrochloride.
•Bottle of 100 tablets with child-resistant closure (NDC 0173-0675-01). •Unit Dose Pack of 24 (NDC 0173-0675-02).
MALARONE Pediatric Tablets, containing 62.5 mg atovaquone and 25 mg proguanil hydrochloride.
•Bottle of 100 tablets with child-resistant closure (NDC 0173-0676-01).
Storage Conditions
Store at 25°C (77°F). Temperature excursions are permitted to 15° to 30°C (59° to 86°F) (see USP Controlled Room Temperature).[1]
References
Adapted from the FDA Package Insert.